“Two-phase”的搜索结果，显示 231-240 项，共有 7536 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts) ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trials studies how well ... two lines of therapy as measured by objective ... phase 2 dose (RP2D) for future study after treatment with ...

6. 血液科- 临床试验- 妙佑医疗国际

   A Phase 1/​2 Study Of STP938 For Adult Subjects With Relapsed/​Refractory B-Cell And T-Cell Lymphomas. Scottsdale/Phoenix, Ariz., Rochester, Minn. The ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase II trials studies how well ... two lines of therapy as measured by objective ... phase 2 dose (RP2D) for future study after treatment with ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...